A large US-based study has found that people with type 2 diabetes taking GLP-1 drugs such as Ozempic may be slightly less ...

A medical expert warned of the side effects of the newly launched weight loss drug and advised that the drug should be taken ...

In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...

The World Health Organization conditionally recommended GLP-1 drugs for obesity. A physician breaks down what you need to ...

This year has been one for the books in medicine. From Ozempic’s expanded role in protecting failing kidneys to long‑acting ...

The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

Introducing Ozempic, a groundbreaking GLP-1 agonist now making waves in India! This innovative treatment emulates a natural ...

Northwell Health reports that "Ozempic face" describes the facial changes from rapid weight loss using Ozempic, highlighting ...

Novo Nordisk has officially launched Ozempic in India for diabetes care. Here's how the injectable works, its dosage options, ...

“Caloric restriction, or fasting, is one of the most well-established interventions for extending lifespan and improving ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.